Optimind Pharma Statistics

Total Valuation

Optimind Pharma has a market cap or net worth of CAD 548,942. The enterprise value is 584,172.

Market Cap	548,942
Enterprise Value	584,172

Important Dates

The next estimated earnings date is Monday, January 20, 2025.

Earnings Date	Jan 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Optimind Pharma has 109.79 million shares outstanding. The number of shares has increased by 10.48% in one year.

Current Share Class	n/a
Shares Outstanding	109.79M
Shares Change (YoY)	+10.48%
Shares Change (QoQ)	-6.56%
Owned by Insiders (%)	3.13%
Owned by Institutions (%)	n/a
Float	106.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.80
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.59
EV / Sales	5.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.66

Current Ratio	0.66
Quick Ratio	0.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-10.80

Financial Efficiency

Return on equity (ROE) is -1,101.07% and return on invested capital (ROIC) is -52.92%.

Return on Equity (ROE)	-1,101.07%
Return on Assets (ROA)	-44.83%
Return on Capital (ROIC)	-52.92%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.20
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.67% in the last 52 weeks. The beta is -0.95, so Optimind Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.95
52-Week Price Change	-66.67%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	44.47
Average Volume (20 Days)	40,979

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Optimind Pharma had revenue of CAD 111,444 and -990,491 in losses. Loss per share was -0.01.

Revenue	111,444
Gross Profit	70,305
Operating Income	-402,262
Pretax Income	-999,250
Net Income	-990,491
EBITDA	n/a
EBIT	-402,262
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 90,410 in cash and 125,637 in debt, giving a net cash position of -35,227 or -0.00 per share.

Cash & Cash Equivalents	90,410
Total Debt	125,637
Net Cash	-35,227
Net Cash Per Share	-0.00
Equity (Book Value)	-39,082
Book Value Per Share	-0.00
Working Capital	-89,082

Full Balance Sheet

Cash Flow

Operating Cash Flow	-218,783
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	63.09%
Operating Margin	-360.95%
Pretax Margin	-896.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Optimind Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.48%
Shareholder Yield	-10.48%
Earnings Yield	-185.06%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Optimind Pharma has an Altman Z-Score of -35.94. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-35.94
Piotroski F-Score	n/a